PETMED EXPRESS INC (PETS)
US7163821066 - Common Stock
Overall PETS gets a fundamental rating of 5 out of 10. We evaluated PETS against 125 industry peers in the Specialty Retail industry. While PETS has a great health rating, there are worries on its profitability. PETS is valied quite expensively at the moment, while it does show a decent growth rate. Finally PETS also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year PETS has reported negative net income.
In the past year PETS had a positive cash flow from operations.
PETS had positive earnings in each of the past 5 years.
PETS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
PETS has a worse Return On Assets (-3.82%) than 63.20% of its industry peers.
PETS has a Return On Equity (-5.35%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.82% | ||
| ROE | -5.35% | ||
| ROIC | N/A |
ROA(3y)9.47%
ROA(5y)13.9%
ROE(3y)12.22%
ROE(5y)16.91%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Profit Margin of PETS has declined.
PETS has a Gross Margin of 27.80%. This is in the lower half of the industry: PETS underperforms 68.80% of its industry peers.
PETS's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for PETS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 27.8% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-79.56%
PM growth 5Y-64.4%
GM growth 3Y-1.11%
GM growth 5Y-5%
2. Health
2.1 Basic Checks
PETS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PETS has more shares outstanding
The number of shares outstanding for PETS has been increased compared to 5 years ago.
There is no outstanding debt for PETS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
PETS has an Altman-Z score of 3.80. This indicates that PETS is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.80, PETS belongs to the top of the industry, outperforming 80.80% of the companies in the same industry.
There is no outstanding debt for PETS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 3.8 |
ROIC/WACCN/A
WACC9.31%
2.3 Liquidity
A Current Ratio of 2.11 indicates that PETS has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.11, PETS is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
PETS has a Quick Ratio of 1.64. This is a normal value and indicates that PETS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.64, PETS belongs to the top of the industry, outperforming 86.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.11 | ||
| Quick Ratio | 1.64 |
3. Growth
3.1 Past
PETS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -137.18%.
The earnings per share for PETS have been decreasing by -59.06% on average. This is quite bad
PETS shows a small growth in Revenue. In the last year, the Revenue has grown by 3.13%.
PETS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.27% yearly.
EPS 1Y (TTM)-137.18%
EPS 3Y-75%
EPS 5Y-59.06%
EPS growth Q2Q-100%
Revenue 1Y (TTM)3.13%
Revenue growth 3Y-3.3%
Revenue growth 5Y-1.27%
Revenue growth Q2Q8.58%
3.2 Future
PETS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 87.86% yearly.
The Revenue is expected to grow by 7.34% on average over the next years.
EPS Next Y-329.5%
EPS Next 2Y67.48%
EPS Next 3Y87.86%
EPS Next 5YN/A
Revenue Next Year8.45%
Revenue Next 2Y7.85%
Revenue Next 3Y7.34%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
PETS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 75.31, the valuation of PETS can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as PETS.
The average S&P500 Price/Forward Earnings ratio is at 21.32. PETS is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 75.31 |
4.2 Price Multiples
PETS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PETS is cheaper than 93.60% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.13 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PETS's earnings are expected to grow with 87.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y67.48%
EPS Next 3Y87.86%
5. Dividend
5.1 Amount
PETS has a Yearly Dividend Yield of 28.99%, which is a nice return.
In the last 3 months the price of PETS has falen by -37.39%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
PETS's Dividend Yield is rather good when compared to the industry average which is at 3.38. PETS pays more dividend than 100.00% of the companies in the same industry.
PETS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 28.99% |
5.2 History
The dividend of PETS is nicely growing with an annual growth rate of 6.52%!
PETS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)6.52%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of PETS are negative and hence is the payout ratio. PETS will probably not be able to sustain this dividend level.
The dividend of PETS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-405.1%
EPS Next 2Y67.48%
EPS Next 3Y87.86%
PETMED EXPRESS INC
NASDAQ:PETS (4/18/2024, 10:14:06 AM)
4.225
+0 (+0.12%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap89.36M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 28.99% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 75.31 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.82% | ||
| ROE | -5.35% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 27.8% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.7
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.11 | ||
| Quick Ratio | 1.64 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-137.18%
EPS 3Y-75%
EPS 5Y
EPS growth Q2Q
EPS Next Y-329.5%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.13%
Revenue growth 3Y-3.3%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y